Murdo Gordon Bristol Myers Squibb CO (BMY) insider trading activity

Murdo Gordon is EVP, Chief Commercial Officer of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 49,423 shares of BMY, which is worth approximately $2.11 Million. The most recent transaction as insider was on Aug 01, 2018, when has been sold 744 shares (Common Stock, $0.10 par value) at a price of $59.62 per share, resulting in proceeds of $44,357. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.4K

0% 3M change

0% 12M change

Total Value Held $2.11 Million

Murdo Gordon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2018	SELL Payment of exercise price or tax liability	$44,357 $59.62 p/Share	744 Reduced 1.48%	49,423 Common Stock, $0.10 pa...
Aug 01 2018	BUY Exercise of conversion of derivative security	-	1,510 Added 2.92%	50,167 Common Stock, $0.10 pa...
Mar 10 2018	SELL Payment of exercise price or tax liability	$1,363,969 $67.92 p/Share	20,082 Reduced 29.21%	48,657 Common Stock, $0.10 pa...
Mar 10 2018	BUY Exercise of conversion of derivative security	-	39,235 Added 38.75%	62,027 Common Stock, $0.10 pa...
Mar 10 2018	BUY Other acquisition or disposition	-	1,537 Added 3.92%	37,623 Common Stock, $0.10 pa...
Aug 01 2017	SELL Payment of exercise price or tax liability	$43,926 $56.1 p/Share	783 Reduced 2.72%	27,967 Common Stock, $0.10 pa...
Aug 01 2017	BUY Exercise of conversion of derivative security	-	1,510 Added 4.99%	28,750 Common Stock, $0.10 pa...

Mar 10 2017	SELL Other acquisition or disposition	-	764 Reduced 3.58%	20,566 Common Stock, $0.10 pa...
Mar 10 2017	SELL Payment of exercise price or tax liability	$747,487 $58.32 p/Share	12,817 Reduced 32.0%	27,240 Common Stock, $0.10 pa...
Mar 10 2017	BUY Other acquisition or disposition	-	764 Added 4.13%	17,747 Common Stock, $0.10 pa...
Mar 10 2017	BUY Exercise of conversion of derivative security	-	25,592 Added 41.62%	35,897 Common Stock, $0.10 pa...
Aug 01 2016	SELL Payment of exercise price or tax liability	$59,733 $76.19 p/Share	784 Reduced 5.14%	14,465 Common Stock, $0.10 pa...
Aug 01 2016	BUY Exercise of conversion of derivative security	-	1,511 Added 9.02%	15,249 Common Stock, $0.10 pa...
Jul 01 2016	SELL Payment of exercise price or tax liability	$89,348 $73.78 p/Share	1,211 Reduced 8.1%	13,738 Common Stock, $0.10 pa...
Jul 01 2016	BUY Exercise of conversion of derivative security	-	2,335 Added 13.51%	14,949 Common Stock, $0.10 pa...
Mar 10 2016	SELL Other acquisition or disposition	-	38 Reduced 0.51%	7,376 Common Stock, $0.10 pa...
Mar 10 2016	SELL Payment of exercise price or tax liability	$693,235 $64.94 p/Share	10,675 Reduced 45.84%	12,614 Common Stock, $0.10 pa...
Mar 10 2016	BUY Other acquisition or disposition	-	1,313 Added 17.84%	6,047 Common Stock, $0.10 pa...
Mar 10 2016	BUY Exercise of conversion of derivative security	-	19,308 Added 49.62%	19,607 Common Stock, $0.10 pa...
Mar 06 2016	SELL Payment of exercise price or tax liability	$72,799 $64.71 p/Share	1,125 Reduced 29.37%	2,706 Common Stock, $0.10 pa...
Mar 06 2016	BUY Other acquisition or disposition	-	1,220 Added 24.15%	3,831 Common Stock, $0.10 pa...
Mar 06 2016	BUY Exercise of conversion of derivative security	-	1,282 Added 32.93%	2,611 Common Stock, $0.10 pa...

Also insider at

AMGN

AMGEN INC Healthcare

EVP, Global Commercial Ops

Murdo Gordon

EVP, Chief Commercial Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Value

Insider Trading

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

Operation

Value

Type

News

Receive news related to BRISTOL MYERS SQUIBB CO

Track Activities on BMY

Account